OpenAlex
PricingAboutJobs
Log inGet started
Work

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

HTML

Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Blood
DOI: 10.1182/blood-2008-05-160143
Authors: Harry R. Buller, Anthonie W. A. Lensing, Martin H. Prins, Giancarlo Agnelli, Alexander Cohen, Alexander S. Gallus, Frank Misselwitz, Gary Raskob, Sebastian Schellong, Annelise Segers
Institutions: Amsterdam UMC Location University of Amsterdam, University of Amsterdam, Maastricht University Medical Centre, Maastricht University, Care and Public Health Research Institute, University of Perugia, King's College London, Flinders Medical Centre, University of Oklahoma, University Hospital Carl Gustav Carus
Language: English

Topic: Venous Thromboembolism Diagnosis and Management
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Keywords: rivaroxaban, deep vein thrombosis, factor Xa inhibitors, dose-ranging, venous thromboembolism, low molecular weight heparin, vitamin K antagonists, major bleeding, anticoagulation
SDG: Good health and well-being

Open Access status: green
OpenAlex ID: W2075359369
FWCI: 32.6
Cites: 22
Cited by: 365
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security